Abstracts Archive - Page 1541 of 2607 - ACR Meeting Abstracts

Abstract Number: 2306 • 2017 ACR/ARHP Annual Meeting
Demographic and Clinical Characteristics of Hispanic Children with Juvenile Idiopathic Arthritis: An International, Multicenter Cross-Sectional Study
Martha Rodriguez¹, Melissa Tesher¹, Deirdre De Ranieri¹, Linda Wagner-Weiner², Tamar Rubinstein³, Janet Orrock⁴, Christine Arango⁵, Angela Mosquera⁵, Carmen Tineo⁶, Romilda Salas⁷, Esthela Loyo⁸, Karen Onel⁹ and Maria Alkureishi¹⁰, ¹Pediatric Rheumatology, The University of Chicago Medicine, Chicago, IL, ²The University of Chicago Medicine, Chicago, IL, ³Albert Einstein College of Medicine, Children's Hospital at Montefiore, New York, NY, ⁴Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, NY, Albania, ⁵Pediatric Rheumatology, Pediatric rheumatology post graduate program El Bosque University, Bogota, Colombia, ⁶Division of Rheumatology, Hospital Regional Universitario José Ma Cabral Baez, Santiego, Dominican Republic, ⁷Rheumatology, Hospital Regional Universitario José Ma Cabral Baez, Santiago, Dominican Republic, ⁸Departamento de Reumatologia, Hospital Regional Universitario José Ma Cabral Baez, Santiago, Dominican Republic, ⁹Division of Pediatric Rheumatology, University of Chicago, Chicago, IL, ¹⁰Pediatrics, The University of Chicago Medicine, Chicago, IL
Background/Purpose: Higher disease activity has been described in Hispanic patients with Juvenile Idiopathic Arthritis (JIA) living in the United States (US) vs non-Hispanics. There is…
Abstract Number: 2307 • 2017 ACR/ARHP Annual Meeting
Frequency of Comorbidities in Patients with Juvenile Ideopathic Arthritis – Results of an Observational Cohort Study
Jens Klotsche¹, Nadine Betenstehl², Gerd Ganser³, Eva Seipelt⁴, Stefanie Tatsis⁵, Heike-Franziska Weidemann⁶, Ivan Foeldvari⁷, Gerd Horneff⁸ and Kirsten Minden⁹, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany, ²Oberhavelkliniken Hennigsdorf, Hennigsdorf, Germany, ³Klinik für Kinder-und Jugendrheumatologie, Nordwestdeutsches Rheumazentrum, Sendenhorst, Germany, ⁴Rheumatologie und Klinische Immunologie, Immanuel Krankenhaus Berlin, Berlin, Germany, ⁵Geriatrie/Rheumatologie, Kath. Marienkrankenhaus Hamburg gGmbH, Hamburg, Germany, ⁶Internist.-Rheum. Praxis Dr. Weidemann, Hannover, Germany, ⁷Hamburger Zentrum für Kinder-und Jugend Rheumatologie, Hamburg, Germany, ⁸Arnold-Janssen-Strasse 29, Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany, ⁹Epidemiology unit, German Rheumatism Research Center, Berlin, Germany
Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease that often persists into adulthood. In addition to disability and poorer quality of life, JIA…
Abstract Number: 2308 • 2017 ACR/ARHP Annual Meeting
The Prevalence of Comorbidities in Pediatric Psoriasis and Juvenile Psoriatic Arthritis
Cuoghi Edens¹, Angela Byun Robinson² and Maria Antonelli³, ¹Division of Pediatric Infectious Diseases and Rheumatology and Division of Rheumatology, Rainbow Babies and Children's Hospital and University Hospitals Cleveland Medical Center, Cleveland, OH, ²Division of Pediatric Infectious Diseases and Rheumatology, Case Western Reserve University School of Medicine, Rainbow Babies and Children’s Hospital, Cleveland, OH, ³Department of Medicine/Division of Rheumatology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, OH
Background/Purpose: Adult-onset psoriasis (PsO) and psoriatic arthritis (PsA) have been associated with increased rates of diabetes, obesity, and hypertension. We sought to evaluate the prevalence…
Abstract Number: 2309 • 2017 ACR/ARHP Annual Meeting
Risk Factors for Arthritis and the Development of Comorbid Cardiovascular and Metabolic Disease in Children with Psoriasis
Cynthia K. Manos^1,2, Rui Xiao³, Timothy G. Brandon¹, Alexis Ogdie⁴ and Pamela F. Weiss^5,6, ¹Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Philadelphia, PA, ³Department of Pediatrics, Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Rheumatology, Hospital of the University of Pennsylvania, Philadelphia, PA, ⁵Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁶Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA
Background/Purpose: Relatively little is known about the epidemiology of juvenile psoriatic arthritis (PsA), including risk factors for development of PsA among children with psoriasis. It…
Abstract Number: 2310 • 2017 ACR/ARHP Annual Meeting
Increased Risk of Extreme Obesity in Adults with History of Childhood Arthritis
Sangeeta Sule¹ and Kevin Fontaine², ¹Pediatrics, Johns Hopkins University, Baltimore, MD, ²Dept. of Health Behavior, Univ. of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Over one-third of U.S. adults are obese, leading to major health conditions and increased costs. Identified risk factors that contribute to obesity include lifestyle,…
Abstract Number: 2311 • 2017 ACR/ARHP Annual Meeting
Prospective Validation of the Juvenile Spondyloarthritis Disease Activity Index and Its Comparison with Adult Spondyloarthritis Disease Activity Scores
Abhishek Zanwar, Sanat Phatak and Amita Aggarwal, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Background/Purpose: Among JIA children with Enthesitis related arthritis (ERA) category have more pain, poorer health status and are less likely to achieve or maintain sustained…
Abstract Number: 2312 • 2017 ACR/ARHP Annual Meeting
Prevalence of Serum 14-3-3η (eta) in Juvenile Idiopathic Arthritis
Iris Reyhan¹, Olga S. Zhukov², Robert J. Lagier³, Robert Bridgforth⁴, Gary J Williams⁵, Joanna M. Popov², Stanley J. Naides² and Andreas Reiff⁶, ¹Rheumatology, Children's Hospital of Los Angeles, Los Angeles, CA, ²Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, ³Research Support, Alameda, Quest Diagnostics Alameda, Alameda, CA, ⁴Quest Diagnostics Nichols Institute, clemente, CA, ⁵Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, ⁶Children’s Hospital of Los Angeles, Los Angeles, CA
Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease. Currently, diagnosis is based on clinical assessment defined by the International League of…
Abstract Number: 2313 • 2017 ACR/ARHP Annual Meeting
Procalcitonin Differentiates Infection from Active Disease in Patients with Juvenile Idiopathic Arthritis
Rebecca Trachtman¹, Elizabeth T. Murray², Nancy Pan³, Sima S Toussi⁴, Marianne E Nellis⁵, Jackie Szymonifka⁶, Sarah Taber³, Alexa Adams³, Thomas J. A. Lehman³, Karen Onel³ and Lisa A. Mandl⁷, ¹Pediatric Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, NY, NY, ²Hospital for Special Surgery, New York, NY, ³Pediatric Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ⁴Pediatric Infectious Disease, Weill Cornell Medical College, New York, NY, ⁵Pediatric Critical Care, Weill Cornell Medical College, New York, NY, ⁶Rheumatology, Hospital for Special Surgery, New York, NY, ⁷Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY
Background/Purpose: Patients with juvenile idiopathic arthritis (JIA) often present with signs and symptoms suggestive of infection. However, it is a diagnostic challenge to differentiate infectious…
Abstract Number: 2314 • 2017 ACR/ARHP Annual Meeting
Monoarticular Juvenile Idiopathic Arthritis: A Unique Entity?
Caterina Politi¹, Vanessa Cecchin¹, Fabio Vittadello¹, Alessandra Meneghel², Giorgia Martini¹ and Francesco Zulian², ¹Department of Woman and Child Health, University of Padua, Padua, Italy, ²University of Padua, Department of Woman and Child Health, Padua, Italy
Background/Purpose: Oligoarticular Juvenile Idiopathic Arthritis (oligoJIA) is the most common JIA subtype. According with the most recent classification criteria1, monoarticular JIA (monoJIA) is included in…
Abstract Number: 2315 • 2017 ACR/ARHP Annual Meeting
Symptoms of Depression and Anxiety in Children with JIA: Relation to Other Domains of Health Related Quality of Life
Michael Miller¹, Yufan Yan² and George Lales³, ¹Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, ²Feinberg School of Medicine, Northwestern University, Chicago, IL, ³Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is associated with symptoms of anxiety and depression. We studied these symptoms and other health related quality of life (HRQOL)…
Abstract Number: 2316 • 2017 ACR/ARHP Annual Meeting
Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) – a Patient Reported Outcome
Kelsey Chomistek¹, Nicole Johnson¹, Rebeka Stevenson¹, Nadia Luca², Paivi Miettunen¹, Susanne Benseler², Dwaraka Veeramreddy³ and Heinrike Schmeling⁴, ¹Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ²Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ³University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ⁴Alberta Children’s Hospital/University of Calgary, Calgary, AB, Canada
Background/Purpose: Few studies in children with chronic illnesses/disability have reported challenges faced by patients at school. Therefore, the objective of this study is to identify…
Abstract Number: 2317 • 2017 ACR/ARHP Annual Meeting
Knowledge Translation in Juvenile Idiopathic Arthritis in Canada: A Focus on Parents of Children with JIA
Julia Wright¹, Benjamin Rose-Davis², Michelle Batthish³, Tania Cellucci⁴, Ciarán M. Duffy⁵, Lori Tucker⁶, Adam Huber⁷, Bianca Lang⁸, Deborah M. Levy⁹, Dax Rumsey¹⁰, Karen N Watanabe Duffy¹¹, Janet Curran¹² and Elizabeth Stringer¹³, ¹Faculty of Medicine, Dalhousie University, Halifax, NS, Canada, ²Department of Computer Science, Health Informatics, Dalhousie University, Halifax, NS, Canada, ³Division of Pediatric Rheumatology, McMaster Children's Hospital, Hamilton, ON, Canada, ⁴McMaster University, hamilton, ON, Canada, ⁵Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁶BC Children's Hospital, Vancouver, BC, Canada, ⁷IWK Health Centre, Halifax, NS, Canada, ⁸Pediatrics, IWK Health Centre, Halifax, NS, Canada, ⁹Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁰Stollery Children's Hospital, Edmonton, AB, Canada, ¹¹Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ¹²Department of Pediatrics, IWK Health Centre, Halifax, NS, Canada, ¹³Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada
Background/Purpose: The Research in Canadian Children with Childhood Arthritis Emphasizing Outcomes (ReACCh-Out) cohort (2005-2010) has characterized outcomes for Canadian children with Juvenile Idiopathic Arthritis (JIA).…
Abstract Number: 2318 • 2017 ACR/ARHP Annual Meeting
Measurement of Serum Infliximab and Antibody Levels As an Adjunct to Clinical Decision Making Regarding Infliximab Therapy
Eileen Pagano¹, Myriam Kline² and B. Anne Eberhard³, ¹Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, ²Biostatistics Unit, Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, ³Pediatric Rheumatology, Cohen Children's Medical Center of New York, Lake Success, NY
Background/Purpose: Infliximab (IFX) is a chimeric monoclonal antibody against tumor necrosis factor alpha (TNF-a). It is known to be effective and often used in the…
Abstract Number: 2319 • 2017 ACR/ARHP Annual Meeting
Bradycardia after High-Dose Solu-Medrol
Deirdre De Ranieri¹ and Umesh Dyamenahalli², ¹Pediatric Rheumatology, The University of Chicago Medicine, Chicago, IL, ²Pediatric Cardiology, University of Chicago, Chicago, IL
Background/Purpose: Methylprednisolone (MP) in both high dose (2mg/kg or higher) and pulse dose (30mg/kg up to 1000mg) is often used to treat patients with connective…
Abstract Number: 2320 • 2017 ACR/ARHP Annual Meeting
Pediatric Rheumatology Infusion Center: Report on Therapeutic Protocols and Infusion Reactions over 4 Years
Annelle Reed¹, Surabhi S. Vinod², Jamelle Maxwell³, Esraa M. A. Eloseily^4,5, Matthew L. Stoll⁴ and Randy Q. Cron⁴, ¹Pediatric rheumatology, Childrens of Alabama, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³Childrens of Alabama, Birmingham, AL, ⁴Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Pediatrics, Assiut University, Assiut, Egypt
Background/Purpose: The goals of this report are to describe various therapeutic protocols, volume of intravenous (IV) infusions, and associated adverse events at the University of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].